A decade after after duping bioethicists, Lilly pulls the plug on Xigris
Remember Xigris? The enormously expensive sepsis drug that Lilly hyped by buying off bioethicists? Ten years after its launch, a new study has shown that Xigris does not help patients live longer, so Lilly is pulling the drug from the market. Read about it here.